Long-term follow-up of liver transplantation for budd-chiari syndrome with antithrombotic therapy based on the etiology

Transplantation

Volumn 92, Issue 3, 2011, Pages 341-345

  Chinnakotla, Srinath ^a   Klintmalm, Goran B ^a   Kim, Peter ^a   Tomiyama, Koji ^a   Klintmalm, Erik ^a   Davis, Gary L ^b   Trotter, James F ^b   Saad, Rana ^a   Landaverde, Carmen ^b   Levy, Marlon F ^c   Goldstein, Robert M ^a   Stone, Marvin J ^a  

^a BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^b Baylor Simmons Transplant Institute   (United States)

^c Baylor All Saints Medical Center   (United States)

Author keywords

Antiplatelet treatment; Budd Chiari syndrome; Myeloproliferative disorder

Indexed keywords

ACETYLSALICYLIC ACID; BLOOD CLOTTING FACTOR 5 LEIDEN; HYDROXYUREA; PROTHROMBIN; WARFARIN;

ABDOMINAL BLEEDING; ADOLESCENT; ADULT; ANEMIA; ANTICOAGULANT THERAPY; ANTIPHOSPHOLIPID SYNDROME; ARTERY OCCLUSION; BUDD CHIARI SYNDROME; CAVA VEIN OBSTRUCTION; CAVA VEIN THROMBOSIS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GRAFT SURVIVAL; GRANULOCYTOPENIA; HEPATIC ARTERY STENOSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERCOAGULABILITY; HYPERHOMOCYSTEINEMIA; LIVER BIOPSY; LIVER TRANSPLANTATION; MALE; MYELOPROLIFERATIVE DISORDER; POLYCYTHEMIA VERA; PORTAL VEIN OBSTRUCTION; PORTAL VEIN THROMBOSIS; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; REVIEW; SARCOIDOSIS; SCHOOL CHILD; SURVIVAL RATE; THROMBOCYTE COUNT; THROMBOCYTHEMIA; TREATMENT INDICATION; VASCULAR DISEASE; VEIN THROMBOSIS;

ADOLESCENT; ADULT; ANTICOAGULANTS; ASPIRIN; BUDD-CHIARI SYNDROME; CHILD; FEMALE; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HEPATIC ARTERY; HUMANS; HYDROXYUREA; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PORTAL VEIN; POSTOPERATIVE COMPLICATIONS; THROMBOSIS; WARFARIN; YOUNG ADULT;

EID: 79961022740     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3182247b05     Document Type: Review

References (27)

1. Ludwig J, Hashimoto E, McGill DB, et al. Classification of hepatic venous outflow obstruction: Ambiguous terminology of the Budd-Chiari syndrome. Mayo Clin Proc 1990; 65: 51.
2. Tanaka M, Wanless IR. Pathology of the liver in Budd-Chiari syndrome: Portal vein thrombosis and the histogenesis of veno-centric cirrhosis, veno-portal cirrhosis, and large regenerative nodules. Hepatology 1998; 27: 488.
3. Klein AS, Molmenti EP. Surgical treatment of Budd-Chiari syndrome. Liver Transpl 2003; 9: 891.
4. Seltman HJ, Dekker A, Van Thiel DH, et al. Budd-Chiari syndrome recurring in a transplanted liver. Gastroenterology 1983; 84: 640.
5. Halff G, Todo S, Tzakis AG, et al. Liver transplantation for the Budd-Chiari syndrome. Ann Surg 1990; 211: 43.
6. Srinivasan P, Rela M, Prachalias A, et al. Liver transplantation for Budd-Chiari syndrome. Transplantation 2002; 73: 973.
7. Cruz E, Ascher NL, Roberts JP, et al. High incidence of recurrence and hematologic events following liver transplantation for Budd-Chiari syndrome. Clin Transplant 2005; 19: 501.
8. Campbell DA Jr, Rolles K, Jamieson N, et al. Hepatic transplantation with perioperative and long term anticoagulation as treatment for Budd-Chiari syndrome. Surg Gynecol Obstet 1988; 166: 511.
9. Klein AS. Management of Budd-Chiari syndrome. Liver Transpl 2006; 12(11 suppl 2): S23.
10. Rajani R, Melin T, Björnsson E, et al. Budd-Chiari syndrome in Sweden: Epidemiology, clinical characteristics and survival-An 18-year experience. Liver Int 2009; 29: 253.
11. Ulrich F, Pratschke J, Neumann U, et al. Eighteen years of liver transplantation experience in patients with advanced Budd-Chiari syndrome. Liver Transpl 2008; 14: 144.
12. Darwish Murad S, Plessier A, Hernandez-Guerra M, et al. Etiology, management, and outcome of the Budd-Chiari syndrome. Ann Intern Med 2009; 151: 167.
13. Melear JM, Goldstein RM, Levy MF, et al. Hematologic aspects of liver transplantation for Budd-Chiari syndrome with special reference to myeloproliferative disorders. Transplantation 2002; 74: 1090.
14. Goldstein R, Clark P, Klintmalm G, et al. Prevention of recurrent thrombosis following liver transplantation for Budd-Chiari syndrome associated with myeloproliferative disorders: Treatment with hydroxyurea and aspirin. Transplant Proc 1991; 23: 1559.
15. Stone MJ, Fulmer JM, Klintmalm GB. Transplantation for Budd-Chiari syndrome. In: Busuttil RW, Klintmalm GB, eds. Transplantation of the liver, 2nd ed. Philadelphia, PA: WB Saunders 2005, p 249.
16. Washburn WK, Gish RG, Kamath PS. Model for end-stage liver disease (MELD) exception for Budd Chiari syndrome. Liver Transpl 2006; 12(suppl 3): S93.
17. Hirshberg B, Shouval D, Fibach E, et al. Flow cytometric analysis of autonomous growth of erythroid precursors in liquid culture detects occult polycythemia vera in the Budd-Chiari syndrome. J Hepatol 2000; 32: 574.
18. Samuelson SJ, Parker CJ, Prchal JT. Revised criteria for the myeloproliferative disorders: Too much too soon? Blood 2008; 111: 1741. (Pubitemid 351213470)
19. Plessier A, Sibert A, Consigny Y, et al. Aiming at minimal invasiveness as a therapeutic strategy for Budd-Chiari syndrome. Hepatology 2006; 44: 1308.
20. Ringe B, Lang H, Oldhafer KJ, et al. Which is the best surgery for Budd-Chiari syndrome: Venous decompression or liver transplantation? A single-center experience with 50 patients. Hepatology 1995; 21: 1337.
21. Jamieson NV, Williams R, Calne RY. Liver transplantation for Budd-Chiari syndrome, 1976-1990. Ann Chir 1991; 45: 362.
22. Shaked A, Goldstein RM, Klintmalm GB, et al. Portosystemic shunt versus orthotopic liver transplantation for the Budd-Chiari syndrome. Surg Gynecol Obstet 1992; 174: 453.
23. Mentha G, Giostra E, Majno PE, et al. Liver transplantation for Budd-Chiari syndrome: A European study on 248 patients from 51 centres. J Hepatol 2006; 44: 520.
24. Westbrook R, Orr D, Heaton N, et al. Predicting thrombotic complications after liver transplantation in patients with Budd Chiari syndrome [abstract]. Liver Transpl 2010; 16: S72.
25. Brunning RD, McKenna RW: Chronic myeloproliferative diseases. Atlas of tumor pathology: Tumors of the bone marrow. Washington, DC: Armed Forces Institute of Pathology 1993, p 193.
26. Michiels JJ, Juvonen E. Proposal for revised diagnostic criteria of essential thrombocythemia and polycythemia vera by the Thrombocythemia Vera Study Group. Semin Thromb Hemost 1997; 23: 339.
27. Spivak JL. Narrative review: Thrombocytosis, polycythemia vera, and JAK2 mutations: The phenotypic mimicry of chronic myeloproliferation. Ann Intern Med 2010; 152: 300.